Akebia Therapeutics, Inc. (AKBA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Akebia Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -77.46x | -5.77x | -4.48x | -1.12x | -1.33x | -1.01x |
| P/B Ratio | 12.70x | -8.15x | -7.60x | 20.17x | 5.07x | 1.57x |
| P/S Ratio | 1.75x | 2.50x | 1.19x | 0.36x | 1.77x | 1.32x |
| Profitability | ||||||
| Gross Margin | 83.3% | 60.6% | 61.9% | 92.3% | 61.5% | 78.3% |
| Operating Margin | 9.9% | -31.5% | -23.8% | -27.6% | -125.0% | -128.2% |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -133.3% | -130.6% |
| EBITDA Margin | 9.2% | -8.6% | -4.2% | 1.0% | -89.7% | -47.5% |
| Liquidity | ||||||
| Current Ratio | 1.13x | 1.41x | 1.18x | 1.43x | 1.04x | 1.98x |
| Quick Ratio | 1.04x | 1.21x | 1.03x | 1.26x | 0.90x | 1.66x |
| Leverage | ||||||
| Debt/Equity | 6.63x | -3.84x | -3.41x | 19.08x | 1.84x | 0.51x |
YoY = year-over-year change. Source: FMP..